Research only
All of alz.org
ALZ.ORG Research Center Alzheimer's Association International Conference ISTAART Journal Grants TrialMatch Press Donate Contact

Primary Care Preconference

Saturday, July 13, 2013
8:30 a.m.-5 p.m.
Alzheimer's Disease in Primary Care Settings
Boston Exhibition & Convention Center, 253ABC

 

 

Overview Learning objectives
Target audience Accreditation statement
Program Co-Chairs Credit designation
Program Disclosure of conflicts of interest

 

 

Overview

Designed for practicing physicians, this preconference will include information and sessions on the following areas:

Target audience

All clinicians involved in the care of or research on individuals with memory or other cognitive complaints, including but not limited to neurologists, psychiatrists, radiologists, geriatricians, and neuropsychologists; as well as researchers, industry and regulatory agencies stakeholders, and others involved in the use of imaging techniques in the study of Alzheimer's disease, related disorders and normal aging.

Program Co-Chairs

Alireza Atri, M.D., Ph.D.
Assistant in Neurology, Memory Disorders Unit, Massachusetts General Hospital
Associate Director, Clinical Programs, Geriatric Research, Education and Clinical Center, ENRM VA, Bedford Medical Center
Instructor in Neurology, Harvard Medical School

Bradford C. Dickerson, M.D., M.MSci.
Director, Frontotemporal Dementia Unit and Director, Laboratory of Neuroimaging,
Co-Director, Neuroimaging Group, Gerontology Research Unit and MA Alzheimer’s Disease Research Center, Massachusetts General Hospital
Associate Professor of Neurology, Harvard Medical School

Eric G. Tangalos, M.D., F.A.C.P., A.G.S.F., C.M.D.
Professor of Medicine and Co-Director for Education
Mayo Clinic Alzheimer’s Disease Research Center

Program

8:30-8:40 a.m.

Welcome and Overview
Co-Chairs: Dr. Alireza Atri, Dr. Bradford Dickerson, Dr. Eric Tangalos

   

8:40-9:05 a.m.

Clinical Diagnosis and Care of Dementia – Why It Matters
Soo Borson, M.D.
Professor of Psychiatry and Behavioral Sciences and Director, Memory Disorders Clinic University of Washington Medical Center

9:05-9:35 a.m.

Alzheimer’s Disease: State of the State
Steven T. Dekosky, M.D.
James Carroll Flippin Professor of Medical Science, Vice President and Dean
University of Virginia School of Medicine

9:35-10:15 a.m.

The New Criteria for Detection and Diagnosis of AD: From Symptoms and Signs to Neuropsychology, Neuroimaging and CSF
Philip Scheltens, M.D., Ph.D.
Professor of Cognitive Neurology and Director of the Alzheimer Center VU University Medical Center in Amsterdam

10:15-10:45 a.m.

Diagnosis of “The Other Dementias”: Not Uncommon or Necessarily Isolated Dr. Bradford Dickerson

10:45-11 a.m.

Break

11-11:30 a.m.

Where the Rubber Meets the Road: Application and Implications of the New AD Criteria for Primary Care Practice
Ronald C. Petersen, M.D., Ph.D.
Director of the Mayo Alzheimer's Disease Research Center
Mayo Clinic

11:30 a.m.-12 p.m.

Panel Q&A
Moderator: Dr. Eric Tangalos

12-1 p.m.

Lunch

1-1:30 p.m.

Sowing the Seeds of Hope: The Potential to Slow Disease Now and Prevent Dementia in the Future
Riesa Sperling, M.D., M.MSci.
Director, Center for Alzheimer's Research and Treatment, Director, Education and Information Transfer Core, and Co-Leader, Neuroimaging Program, Massachusetts Alzheimer's Disease Research Center
Professor of Neurology, Harvard Medical School

1:30-2:10 p.m.

Pharmacological Treatment of Alzheimer’s Disease: Evidence, Expectations and Ambiguities
Dr. Alireza Atri

2:10-2:45 p.m.

The Importance of Family/Caregivers in the Care of People with Alzheimer’s
James E. Galvin, M.D., M.P.H.
Professor of Neurology, Psychiatry, Nutrition and Population Health
Director of Clinical Operations, Comprehensive Center on Brain Aging
Director, Pearl Barlow Center for Memory Evaluation and Treatment
Associate Director and Education Core Leader, Alzheimer Disease Center
New York University Langone School of Medicine

2:45-3 p.m.

Break

3-3:20 p.m.

Driving and Dementia
David B. Carr, M.D.
Associate Professor of Medicine and Neurology and Clinical Director for the Division of Geriatrics and Nutritional Science, Washington University School of Medicine

3:20-3:50 p.m.

The Front Lines: A Non-Pharmacological Approach to Neuropsychiatric Symptoms and Problem Behaviors in Dementia
Helen C. Kales, M.D.
Associate Professor, Department of Psychiatry University of Michigan

3:50-4:20 p.m.

Backed-Up Against the Wall: Pharmacology to Assuage the PAADS (Psychosis, Apathy, Agitation, Depression, Sleep Problems) Clusters in Dementia
Peter V. Rabins, M.D., M.P.H.
The Richman Family Professor for Alzheimer's and Related Disease
Co-Director, Division of Geriatric Psychiatry and Neuropsychiatry
Director, Geriatric Psychiatry Program, Director, Geriatric Psychiatry Inpatient Unit, and Director, Geriatric Psychiatry Mobile Treatment

4:20-4:50 p.m.

Panel Q&A
Moderator: Margaret M. Noel, M.D., F.A.C.P.
Founder, Director Emeritus, MemoryCare, North Carolina
Clinical Assistant Professor of Family Medicine,
University of North Carolina Medical School

4:50-5 p.m.

Closing remarks
Co-Chairs: Dr. Atri, Dr. Dickerson, Dr. Tangalos

   

Learning objectives

At the end of this educational activity, attendees should be able to:

Accreditation statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Alzheimer's Association. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit designation

The Postgraduate Institute for Medicine designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of conflicts of interest

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.


AAIC 2013 program

View the 2013 schedule and conference program.

Registered attendees have exclusive access to the 2013 AAIC mobile app with full speaker and session listings as well as abstract content. Attendees can email aaic@alz.org for download instructions.


 

2013 Primary Care Sponsors

Lilly

Make history at AAIC 2013 • Boston, MA • July 13-18, 2013